Fortress Biotech, Inc. — Director's Dealing 2012

Jan 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORONADO BIOSCIENCES INC (CNDO)
CIK: 0001429260
Period of Report: 2012-01-11

Reporting Person: SANDAGE BOBBY W PHD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-12	Common Stock, par value $0.001	P	1000	$5.1952	Acquired	1500	Direct
2012-01-11	Common Stock, par value $0.001	P	500	$5.284	Acquired	500	Direct

Footnotes

F1: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $5.18 to $5.20. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $5.28 to $5.29. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.